Chemical M&A: Pent-up Demand For Scale, Growth -- And Defensive Realignment

Research evidence excerpt

Chemical M&A: Pent-up Demand For Scale, Growth -- And Defensive Realignment

USA | Chemicals EquityJuneResearch18, 2026

Chemical M&A: Pent-up Demand For Scale,

Growth -- And Defensive Realignment

Recent chemical sector M&A has aligned with our 5 themes: SMID downstream

chemicals chasing scale and reducing volatility; consolidation in fragmented

markets where digitalization amplifies economies of scale; larger companies

pruning lower-margin businesses with tangled supply chains; emerging market

champions angling for asset-intensive businesses that are globally relevant and

differentiated; and moves to fix vulnerabilities and trough-cycle risks.

Incentives for M&A: In a more challenging growth environment, scale is a path to multiple

expansion (Charts 1, 2). Controlling for differences in margins, financial leverage and FCF

conversion, each $1bn increase in EBITDA lifts EV/EBITDA multiples ~47bps. Our more detailed

segment regressions suggest that for quality businesses, the best lever to improve multiples

is margin (often viewed as "sticky"), whereas for most chemical companies, the focus should

be on organic growth and FCF/Sales, and for more volatile companies, reducing volatility and

deleveraging (rather than, for example, protecting "peak EBITDA"). This can be an argument in favour

of moves to increase vertical integration, which investors have framed for decades as an excuse

for drift. If managements can expect a 3x lift in multiples, for example, the typical company could

lift its share price 25%, we estimate, even while losing ~10% of EBITDA.

Shifting Capital Deployment: Our default forecast is that companies deploy excess capital on

buybacks. We sketch our framework for how financial leverage, margin trends, FCF generation,